JENNIFER BADER: Open Payments
NPI 1407163983 · NEW CASTLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 27 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $134 |
| Ferring Pharmaceuticals Inc. | 5 | $102 |
| Sumitomo Pharma America, Inc. | 5 | $98 |
| CIVCO Medical Instruments | 1 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Astellas Pharma US Inc | 1 | $27 |
| Blue Earth Diagnostics | 1 | $27 |
| Teleflex LLC | 1 | $25 |
Products named: Nubeqa, ADSTILADRIN, GEMTESA, LYNPARZA, PLUVICTO, ORGOVYX, KEYTRUDA, Xtandi.
Industry payments across DE — which companies pay providers there.
